Abstract
Tau protein is a microtubule-stabilising protein whose aggregation is linked to Alzheimer's Disease and other forms of dementia. Tau biology is at the heart of cytoskeletal dynamics and neurodegenerative mechanisms, making it a crucial protein to study. Tau purification, however, is challenging as Tau is disordered, which makes it difficult to produce in recombinant system and is degradation-prone. It is thus challenging to obtain pure and stable preparations of Tau. Here, we present a fast and robust protocol to purify Tau recombinantly in Escherichia coli. Our protocol allows purifying Tau either tag-less or FLAG-tagged at its N-terminus, and Tau fragments of interest. By exploiting a cleavable affinity tag and two anion exchange columns, we obtained Tau preparations of high purity, stable and suitable for in vitro studies, including aggregation experiments that resemble neurodegenerative processes.
| Original language | English |
|---|---|
| Pages (from-to) | 447-455 |
| Number of pages | 9 |
| Journal | Protein Engineering, Design and Selection |
| Volume | 31 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 1 Dec 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alzheimer’s disease
- neurodegeneration
- protein aggregation
- protein purification/intrinsically disordered protein
- protein aggregate
- recombinant protein
- tau protein
- amino acid sequence
- biosynthesis
- chemistry
- genetic engineering
- genetics
- human
- isolation and purification
- mutation
- procedures
Fingerprint
Dive into the research topics of 'Recombinant production and purification of the human protein Tau'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver